CSPC Innovation Pharmaceutical Co., Ltd. (300765.SZ)
CNY 43.15
(2.62%)
CNY 43.15
(2.62%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 891.34 Million CNY | -9.51% |
| 2022 | 855.58 Million CNY | 116.46% |
| 2021 | 395.25 Million CNY | 9.79% |
| 2020 | 360.02 Million CNY | 8.17% |
| 2019 | 332.83 Million CNY | 20.22% |
| 2018 | 276.85 Million CNY | 15.02% |
| 2017 | 240.7 Million CNY | -2.83% |
| 2016 | 247.72 Million CNY | 82.46% |
| 2015 | 135.77 Million CNY | 8.7% |
| 2014 | 124.9 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | -47.48 Million CNY | -775.67% |
| 2024 Q1 | 56.15 Million CNY | -65.08% |
| 2024 Q2 | -5.42 Million CNY | -109.66% |
| 2023 Q1 | 214.53 Million CNY | -29.18% |
| 2023 Q2 | 251.87 Million CNY | 17.41% |
| 2023 Q4 | 160.82 Million CNY | -25.13% |
| 2023 FY | 774.21 Million CNY | -9.51% |
| 2023 Q3 | 214.81 Million CNY | -14.71% |
| 2022 Q3 | 189.57 Million CNY | -15.37% |
| 2022 FY | 855.58 Million CNY | 116.46% |
| 2022 Q4 | 302.94 Million CNY | 59.8% |
| 2022 Q2 | 224 Million CNY | 61.09% |
| 2022 Q1 | 139.05 Million CNY | 45.2% |
| 2021 Q2 | 100.06 Million CNY | -1.64% |
| 2021 FY | 395.25 Million CNY | 9.79% |
| 2021 Q3 | 97.68 Million CNY | -2.39% |
| 2021 Q4 | 95.76 Million CNY | -1.96% |
| 2021 Q1 | 101.73 Million CNY | 100.54% |
| 2020 FY | 360.02 Million CNY | 8.17% |
| 2020 Q4 | 50.73 Million CNY | -47.31% |
| 2020 Q3 | 96.28 Million CNY | -23.3% |
| 2020 Q1 | 87.46 Million CNY | 29.55% |
| 2020 Q2 | 125.54 Million CNY | 43.54% |
| 2019 Q3 | 94.67 Million CNY | -5.92% |
| 2019 Q2 | 100.62 Million CNY | 43.7% |
| 2019 FY | 332.83 Million CNY | 20.22% |
| 2019 Q4 | 67.51 Million CNY | -28.69% |
| 2019 Q1 | 70.02 Million CNY | 8.94% |
| 2018 Q1 | 62.47 Million CNY | 19.65% |
| 2018 FY | 276.85 Million CNY | 15.02% |
| 2018 Q4 | 64.27 Million CNY | -15.09% |
| 2018 Q3 | 75.69 Million CNY | -0.18% |
| 2018 Q2 | 75.83 Million CNY | 21.38% |
| 2017 Q4 | 52.21 Million CNY | 0.0% |
| 2017 Q2 | 67.56 Million CNY | 0.0% |
| 2017 Q3 | 52.21 Million CNY | -22.72% |
| 2017 FY | 240.7 Million CNY | -2.83% |
| 2017 Q1 | 67.56 Million CNY | 0.0% |
| 2016 FY | 247.72 Million CNY | 82.46% |
| 2015 FY | 135.77 Million CNY | 8.7% |
| 2014 FY | 124.9 Million CNY | 0.0% |